A 24-Week, Randomized, Controlled Study to Evaluate the Tolerability, Safety and Efficacy of 2 Different Titration Schemes of the Rivastigmine Patch in Japanese Patients with Mild to Moderate Alzheimer's Disease

A 24-Week, Randomized, Controlled Study to Evaluate the Tolerability, Safety and Efficacy of 2 Different Titration Schemes of the Rivastigmine Patch in Japanese Patients with Mild to Moderate Alzheimer's Disease

Aim: To investigate whether 1-step titration of the rivastigmine patch (initiated at 5 cm2 and titrated to 10 cm2 after 4 weeks) is well tolerated in Japanese patients with Alzheimer's disease (AD) as compared to 3-step titration (initiated at 2.5 cm2 and titrated by 2.5 cm2 every 4 weeks to 10...

Full description

Bibliographic Details
Main Authors: Yu Nakamura, Christine Strohmaier, Kaoru Tamura, Naoko Kataoka, Masayuki Nakano, Shoichiro Oda, Kazuma Nishimura, Akira Homma
Format: Article
Language:English
Published: Karger Publishers 2015-09-01
Series:Dementia and Geriatric Cognitive Disorders Extra
Subjects:
Alzheimerߣs disease
Cholinesterase inhibitors
Japan
Randomized clinical trial
Rivastigmine patch
Titration scheme
Online Access:http://www.karger.com/Article/FullText/439269

Internet

http://www.karger.com/Article/FullText/439269

Similar Items